Abstract
ASM and the Foundation for Innovative New Diagnostics (FIND) signed a Memorandum of Understanding (MOU) on 31 July 2008 confirming their agreement to work in partnership for projects aimed at strengthening infectious disease diagnosis and service integration in resource-limited and transitional countries. FIND is a nonprofit organization based in Geneva, Switzerland. Its mission is to drive the development and implementation of accurate and affordable diagnostic tests that are appropriate to patient care in low-resource settings. FIND's disease portfolio currently includes tuberculosis (TB), malaria, and human African trypanosomiasis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
